Monthly Archives: May 2016

PwC data collection period starts tomorrow – please get involved!

Pharmacy teams in England are reminded that the ‘advice on self-care or over-the-counter (OTC) medicines’ data collection period starts tomorrow, Wednesday 1st June. The data collection activity will contribute to the PricewaterhouseCoopers (PwC) independent assessment for PSNC on the social value of community pharmacy.  Pharmacy teams are asked to complete a simple data collection form over a...

By |May 31st, 2016|Lexpos News|Comments Off on PwC data collection period starts tomorrow – please get involved!

Health & Care Review

Keeping up with all the latest developments in health and care policy could almost be a full time job and PSNC regularly receives questions from LPCs and pharmacy contractors about what is going on in the wider health and care landscape beyond community pharmacy. To help answer some of these questions and to help contractors and...

By |May 27th, 2016|Lexpos News|Comments Off on Health & Care Review

Assessing the social value of community pharmacy – have you completed the survey yet?

Pharmacy teams in England have been busy completing the survey on ‘additional activities relating to dispensing prescriptions’ and submitting their data, which will be used for the PricewaterhouseCoopers (PwC) independent assessment for PSNC on the social value of community pharmacy. However, if you’ve not had time to complete this yet, you still have until Sunday 5th June to...

By |May 27th, 2016|Lexpos News|Comments Off on Assessing the social value of community pharmacy – have you completed the survey yet?

Professional standards webinar

We received some very useful feedback during our recent webinar on the draft professional standards. We’re very grateful to everyone who was able to take part.

You can watch and listen to a recorded version of the webinar here.

By |May 26th, 2016|Lexpos News|Comments Off on Professional standards webinar

Dypiridamole 200mg/5ml oral suspension deleted from Part VIIIB of June Drug Tariff

Effective from 1st June 2016, Dypiridamole 200mg/5ml oral suspension has been deleted from Part VIIIB of the Drug Tariff. This is because a licenced alternative, Dypiridamole 200mg/5ml oral suspension sugar free, is now available and has been added to Part VIIIA of in June’s tariff. Changes to the Drug Tariff impact on reimbursement so it’s...

By |May 26th, 2016|Lexpos News|Comments Off on Dypiridamole 200mg/5ml oral suspension deleted from Part VIIIB of June Drug Tariff